OOIR: Observatory of International Research

Papers

(The median citation count of Best Practice & Research in Clinical Rheumatology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
The importance of functional genomics studies in precision rheumatology	103
Novel therapies – IMID Co-morbidities	90
Update of imaging in the assessment of axial spondyloarthritis	82
CAR T-cell therapy and indications for pediatric rheumatology	82
Possible future avenues for myositis therapeutics: DM, IMNM and IBM	62
A review of the advances in understanding the genetic basis of spondylarthritis and emerging clinical benefit	48
Predicting and preventing clinical psoriatic arthritis	47
Raynaud's phenomenon and digital ulceration in systemic sclerosis	46
Novel therapies in Sjögren’s disease: A systematic review of the literature	43
Rehabilitation interventions in osteoarthritis	43
Epidemiology of rheumatic diseases in tropical populations	40
Erratum to “Editorial Board” [Best Pract Res Clin Rheumatol (2025) 102094]	38
Environmental factors and rheumatic diseases	34
Novel therapies for axial spondyloarthritis and future directions	34
Oral and maxillofacial manifestations of systemic sclerosis	34
Rheumatic manifestations of HIV/AIDS	28
The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus	28
The inequity of global healthcare in pediatric rheumatology	27
Pathophysiology and immunolgical basis of axial spondyloarthritis	27
Index for PART A	26
Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases	25
Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus	24
Global epidemiology of psoriatic arthritis	24
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis	24
Genetics of osteoarthritis	24

Diagnostic delay in axial spondylarthritis: A lost battle?	23
Osteoporosis in 2022: Care gaps to screening and personalised medicine	23
Decoding pain in axial spondyloarthritis: Mechanisms, management, and future directions	23
The challenges in managing Psoriatic Arthritis in resource poor settings	23
Difficult to treat disease in psoriatic arthritis- is it different from axial spondyloarthritis?	23
The role of ultrasound and magnetic resonance imaging in the assessment of musculoskeletal involvement in systemic lupus erythematosus: A review of recent advances and insights	23
Editorial Board	23
Genetics of rheumatoid arthritis	23
CAR T cell therapy: Autoimmune neurological uses and neurotoxicities	22
Physiotherapy and occupational therapy in rheumatoid arthritis: Bridging functional and comorbidity gaps	22
Preclinical RA: How to halt its progression	22
Novel therapies and innovation for systemic sclerosis skin ulceration	21
Patient-reported outcomes in vasculitis	21
Index	20
Editorial Board	20
Where is bone science taking us?	20
Pregnancy & neonatal outcomes in spondyloarthritis	19
Editorial Board	19
Imaging of crystal-induced arthropathies in 2025	19
Improving quality of care in systemic sclerosis	19
Systemic lupus erythematosus	19
Classification of systemic lupus erythematosus: From the development of classification criteria to a new taxonomy?	19
Bedside labial salivary gland biopsy (LSGBx: Lip biopsy): An update for rheumatologists	19
The burden of osteoarthritis: Is it a rising problem?	19
Gastrointestinal involvement in systemic sclerosis: A spotlight on small bowel involvement, complications and management	18
Lacrimal and salivary gland ultrasound - how and when to use in patients with primary Sjögren's syndrome	18
Calcinosis in dermatomyositis: Origins and possible therapeutic avenues	18
Novel biomarkers in RA: Implication for diagnosis, prognosis, and personalised treatment	18
Problems with “Problems with opioids beyond misuse”	17
Malignancy and rheumatic diseases	17
New and future therapies: Changes in the therapeutic armamentarium for SLE	17
Imaging rheumatology: Emerging tools and expanding applications	17
Infection associated Vasculitides	16
Novel therapies in treatments of SLE	16
CAR-T cell therapy for ANCA-associated vasculitis: Rationale, current evidence, and future directions	16
Editorial Board	15
Pregnancy in systemic lupus erythematosus	14
Risk for osteoporosis and fracture with glucocorticoids	14
Granzyme K+ CD8 T cells in autoimmunity	14
Exercise in myositis: What is important, the prescription or the person?	14
Editorial Board	13
Emerging insights in tropical rheumatology: Challenges, clinical manifestations, and recent advances	13
Index	12
What the rheumatologist needs to know about skin biopsy	12
Pharmacogenetics of therapies in rheumatoid arthritis: An update	11
Exploring osteoarthritis: Unraveling challenges, innovations, and hope for a better future	11
Clinical assessment of Psoriatic Arthritis	11
Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment	11
Best practice and research advances in many aspects of rheumatology	11
Personalized medicine in rheumatoid arthritis: Combining biomarkers and patient preferences to guide therapeutic decisions	11

Regenerative methods in osteoarthritis	11
Musculoskeletal complications in sickle cell disease: Pathophysiology, diagnosis and management	10
Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus	10
Pain in osteoarthritis from a symptom to a disease	10
Idiopathic inflammatory myopathies: Progress, challenges, and future perspectives	10
When are patients with osteoarthritis referred for surgery?	10
Synovial fluid analysis: Relevance for daily clinical practice	10
Recent targets of osteoarthritis research	9
TNFR2 signalling in inflammatory diseases	9
Impact of sex and gender on axSpA diagnosis and outcomes	9
Editorial Board	9
Physical rehabilitation interventions for hand function in people with systemic sclerosis	9
Treatment of rheumatic adverse events of cancer immunotherapy	9
Juvenile systemic sclerosis	9
Diabetes and osteoporosis – Treating two entities: A challenge or cause for concern?	8
Osteoporosis evaluation and treatment recommendations in rheumatoid arthritis	8
Muscle imaging in myositis: MRI, US, and PET	8
Femoroacetabular impingement – What the rheumatologist needs to know	8
Practical utilization of sonography for the assessment of muscle diseases in rheumatology	8
Interferonopathies: From concept to clinical practice	8
Novel Therapy	8
IgG4-Related disease: From diagnosis to remission	8
Novel therapies in axial spondyloarthritis	7
Imaging in sarcoid disease	7
CARD9 in the pathogenesis of axial spondyloarthritis	7
Pain syndromes	7
Novel therapies in SSc	7
Preface: Pediatric rheumatology	7
Pain mechanisms for the practicing rheumatologist	7
Exploring the role of gut microbes in spondyloarthritis: Implications for pathogenesis and therapeutic strategies	7
Insights into the genetic landscape of systemic sclerosis	7
Tropical pyomyositis	6
Editorial Board	6
Horizon scan: State-of-the-art therapeutics for psoriatic arthritis	6
Pipeline treatments on psoriatic disease	6
The global burden of fragility fractures – what are the differences, and where are the gaps	6
Advances in imaging techniques for Sjogren's disease	6
Cardiovascular risk in vasculitis	6
Promise of rheumatoid arthritis therapy: From clinical deep remission to drug-free remission	6
Interstitial lung disease imaging for autoimmune diseases	6
Myofascial pain – A major player in musculoskeletal pain	6
Screening, monitoring and treatment of interstitial lung disease in systemic sclerosis	5
To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question	5
Genetics of vasculitis	5
New developments in ultrasound and MRI imaging of pediatric rheumatic diseases	5
How to treat monogenic SLE?	5
Vascular ultrasound in rheumatology practice	5
Treatment overview of axial spondyloarthritis in 2023	5
Utility of polygenic risk scores to aid in the diagnosis of rheumatic diseases	5
Microbiota and immune dynamics in rheumatoid arthritis: Mechanisms and therapeutic potential	5
Challenges in the diagnosis of axial spondyloarthritis	4
Musculoskeletal manifestations in leprosy	4
Osteoporosis and fragility fractures – Why is there still avoidable disability and death?	4
CAR T-cell therapy “Living drugs” in systemic lupus erythematosus	4
The promise of imaging in psoriatic arthritis	4
Magnetic resonance imaging in spondyloarthritis: Friend or Foe?	4
Practical approaches for clinicians in chronic pain management: Strategies and solutions	4
Editorial Board	4
Management of pregnant with rheumatoid arthritis: Preconception care, pregnancy and lactation strategies, and maternal-fetal outcomes	4
Non-coding DNA variants for risk in lupus	4
Cancer and myositis: Who, when, and how to screen	4
What is new in pharmacological treatment for osteoarthritis?	4